Racheli Ofir

Racheli Ofir is a CEO&CTO at Betalin Therapeutics Ltd., with over 15 years of experience in the biotechnology industry. Racheli has a Ph.D. from Technion and a MA in Patent Law from the University of Haifa. Prior to their current role, Racheli worked at Pluristem Therapeutics as VP of Research & Intellectual Property, and at Technion as a Post Doctoral Fellow focusing on molecular embryology research.